Matthew Burke, MBA, RN, MSN, APRN-BC

home / authors / matthew-burke-mba-rn-msn-aprn-bc

Articles

Matthew Burke on Potential Challenges Facing Nurses in the Field of Immunotherapy

Matthew Burke on Potential Challenges Facing Nurses in the Field of Immunotherapy

August 25th 2014

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses potential challenges nurses might face with the new advent on immunotherapy.

Matthew Burke on Immune-Mediated Adverse Events

Matthew Burke on Immune-Mediated Adverse Events

May 5th 2014

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses managing immune-mediated adverse events (IMAEs)

Matthew Burke Discusses Adverse Events

Matthew Burke Discusses Adverse Events

March 5th 2014

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses the difference between adverse events caused by chemotherapy and immunotherapy.

Matthew Burke on the Prevalence of Immunotherapy AEs

Matthew Burke on the Prevalence of Immunotherapy AEs

February 7th 2014

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carincoma, Yale-New Haven Hospital, discusses the prevalence of immunotherapy-related adverse events.

© 2023 MJH Life Sciences

All rights reserved.